Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postpartum malaria prevention and infant ACT pharmacokinetics trial in Papua New Guinea
ACTRN12620000942954Phase 4Recruiting
- Sponsor
- The University of Western Australia
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of artemether + lumefantrine and dihydroartemisinin + piperaquine in malaria (5 arms), sponsored by The University of Western Australia. Primary endpoints: Incidence of malaria infection in postpartum women by microscopy and Incidence of malaria infection in postpartum women by PCR. Started Aug 2018; status: recruiting.
02
Drugs
artemether + lumefantrinedihydroartemisinin + piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on ACTRN12620000942954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000942954.